Remove Marketing Remove Pharma Companies Remove Regulation
article thumbnail

The drug industry continues to dare regulation

World of DTC Marketing

The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients — and especially the pharma companies that promote them — but a wrong long-term value for healthcare costs. The post The drug industry continues to dare regulation appeared first on World of DTC Marketing.com.

article thumbnail

AI in Pharma Marketing: Innovation or Compliance Nightmare?

Pharma Marketing Network

Artificial intelligence (AI) is no longer a futuristic concept in healthcareits here, embedded in nearly every touchpoint of modern pharma marketing. But as pharma marketers race to adopt these tools, a central question looms: Is AI fueling smarter engagement, or setting the stage for a compliance disaster?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

International companies investing in the emerging market of Brazilian pharmaceutical manufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.

article thumbnail

Biogen continues to sink

World of DTC Marketing

What has/is happening at Biogen is a train wreck, and the only way to correct this disaster is to tear it down and rebuild the company from the top down. ” To me, an enormous warning flag went up when the VP of Market Access was on a call with the commercial organization (sales). Click to Tweet.

article thumbnail

What can pharma marketing learn from other regulated industries?

pharmaphorum

N o one industry is ever quite like another, but there are some valuable lessons for pharma marketing from examining how the financial sector uses technology, builds brands on social channels and approaches digital content. Engagement channels. Joanna Carlish. Content consistency.

article thumbnail

UK Regulator Fines Pharma Companies for 10,000% Drug Price Increase

BioSpace

?The CMA said some pharmaceutical firms charge the NHS with excessively high prices for hydrocortisone tablets and paid off potential competitors to stay out of the market.

article thumbnail

Four things you need to know about FDA regulations and digital health

pharmaphorum

If you work in pharma, the chances are you’re no stranger to the United States Food and Drug Administration, or FDA, which regulates pharmaceuticals. While the FDA is responsible for regulating both drugs and devices, they’re handled through completely different processes in different parts of the agency.